These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21362226)

  • 1. [Significance of methylation status of zo-1 gene in differential diagnosis for myelodysplastic syndrome].
    Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):76-80. PubMed ID: 21362226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
    Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):746-9. PubMed ID: 26117030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma].
    Diao YQ; Qu F; Yang MJ; Meng JH; Zhu XL; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):619-23. PubMed ID: 24927439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):455-9. PubMed ID: 25948204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of zo-1 and id4 gene abnormal methylation in multiple myeloma].
    Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1192-7. PubMed ID: 21129259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
    Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
    Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
    Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
    Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
    Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
    Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
    Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
    Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
    Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
    Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
    Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
    Qian J; Chen XX; Qian W; Yang J; Wen XM; Ma JC; Deng ZQ; Qian Z; Zhang YY; Lin J
    Clin Chem Lab Med; 2014 Dec; 52(12):1859-65. PubMed ID: 25153418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study on difference of Id4 gene methylation in various types of myelodysplastic syndromes].
    Zhao Y; Bo J; Dou LP; Jing Y; Wang SH; Wang QS; Li HH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):618-20. PubMed ID: 19549375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
    Feng BZ; Lei JL; Han JZ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
    Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
    J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.